Mirae Asset Global Investments’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.3K | Buy |
1,932
+287
| +17% | +$3.17K | ﹤0.01% | 1394 |
|
|
2025
Q1 | $15.2K | Buy |
1,645
+6
| +0.4% | +$55 | ﹤0.01% | 1418 |
|
|
2024
Q4 | $15.7K | Sell |
1,639
-130
| -7% | -$1.25K | ﹤0.01% | 1452 |
|
|
2024
Q3 | $14.3K | Buy |
1,769
+317
| +22% | +$2.57K | ﹤0.01% | 1474 |
|
|
2024
Q2 | $12.1K | Sell |
1,452
-51,424
| -97% | -$428K | ﹤0.01% | 1442 |
|
|
2024
Q1 | $557K | Buy |
52,876
+7,509
| +17% | +$79.1K | ﹤0.01% | 1846 |
|
|
2023
Q4 | $510K | Buy |
45,367
+835
| +2% | +$9.39K | ﹤0.01% | 1962 |
|
|
2023
Q3 | $384K | Buy |
44,532
+1,993
| +5% | +$17.2K | ﹤0.01% | 2014 |
|
|
2023
Q2 | $440K | Sell |
42,539
-10,521
| -20% | -$109K | ﹤0.01% | 2002 |
|
|
2023
Q1 | $576K | Buy |
53,060
+6,949
| +15% | +$75.4K | ﹤0.01% | 1854 |
|
|
2022
Q4 | $517K | Buy |
46,111
+4,760
| +12% | +$53.4K | ﹤0.01% | 1873 |
|
|
2022
Q3 | $419K | Buy |
41,351
+6,557
| +19% | +$66.4K | ﹤0.01% | 1982 |
|
|
2022
Q2 | $315K | Buy |
+34,794
| New | +$315K | ﹤0.01% | 1963 |
|
|
2022
Q1 | – | Sell |
-10,022
| Closed | -$110K | – | 1636 |
|
|
2021
Q4 | $110K | Buy |
+10,022
| New | +$110K | ﹤0.01% | 1545 |
|